A marriage of formal methods and LLMs seeks to harness the strengths of both.

PriceSmart’s (NASDAQ: PSMT) stock price action cleared a significant hurdle in 2025, crossing to new all-time highs early in the year. The move signals a base case for $45 upside: the market broke out ...

Citigroup projects Bitcoin could reach $143,000 in 12 months (62% upside from $87,000) with a bull case of $189,000 and bear case of $78,500. Citi’s base case expects $15 billion in spot Bitcoin ETF ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is among the best NASDAQ stocks under $10 to buy. As of December 15, Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) has a ‘Hold’ or equivalent rating from ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

Recursion Pharmaceuticals owns the largest supercomputer in the pharmaceutical industry. However, Eli Lilly is starting to build one that could be even more powerful once it's completed. With its ...

OPEC+ is currently expected to focus on reviving another modest sliver of oil production in December as a base case when key members meet this weekend, according to two delegates. The group led by ...

Base Power has built one of the largest battery storage systems in Texas in two years — and now it wants to grow faster. The Austin-based startup, which had raised $200 million in April, is back with ...

In the end, the question that matters is not whether Bagram is valuable. It is. The right question is who President Trump should partner with to gain control over it. President Donald Trump has long ...